Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 6/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | PNMT | P11086 | 1/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.33 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28946005 | 0.88 | MEN1 (0.37) | MEN1SIGMAR1HTR2AHTR2C | |
| SCHEMBL175960 | 0.81 | MEN1 (0.39) | MEN1SIGMAR1HTR2A | |
| SCHEMBL29080999 | 0.78 | MEN1 (0.38) | MEN1SIGMAR1HTR2A | |
| SCHEMBL8818814 | 0.77 | HTR2A (0.40) | MEN1SIGMAR1HTR2AHTR2CPNMT | |
| SCHEMBL34420059 | 0.75 | MEN1 (0.41) | MEN1SIGMAR1HTR2AHTR2C | |
| SCHEMBL7175933 | 0.75 | MEN1 (0.41) | MEN1SIGMAR1HTR2AHTR2C | |
| SCHEMBL8819743 | 0.72 | HTR2A (0.36) | MEN1SIGMAR1HTR2AHTR2C | |
| SCHEMBL10952661 | 0.70 | LMNA (0.49) | SIGMAR1HTR2A | |
| SCHEMBL29501701 | 0.70 | SIGMAR1 (0.43) | SIGMAR1HTR2A | |
| SCHEMBL3262621 | 0.70 | PGR (0.33) | MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1997036588-A3 | USE OF 1,1-DIALKYL-1,2,3,4-TETRAHYDROISOQUINOLINES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF PSYCHOSIS AND PAIN | LEDERLE JAPAN LTD (JP) | 1997-12-24 | — | — | WO | disclosed |
| WO-1997036588-A3 | USE OF 1,1-DIALKYL-1,2,3,4-TETRAHYDROISOQUINOLINES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF PSYCHOSIS AND PAIN | LEDERLE JAPAN LTD (JP) | 1997-12-24 | — | — | WO | disclosed |
| WO-1997036588-A2 | USE OF 1,1-DIALKYL-1,2,3,4-TETRAHYDROISOQUINOLINES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF PSYCHOSIS AND PAIN | LEDERLE (JAPAN), LTD. (JP) | 1997-10-09 | — | — | WO | disclosed |
| WO-1997036588-A2 | USE OF 1,1-DIALKYL-1,2,3,4-TETRAHYDROISOQUINOLINES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF PSYCHOSIS AND PAIN | LEDERLE (JAPAN), LTD. (JP) | 1997-10-09 | — | — | WO | disclosed |
| WO-1997036588-A2 | USE OF 1,1-DIALKYL-1,2,3,4-TETRAHYDROISOQUINOLINES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF PSYCHOSIS AND PAIN | LEDERLE (JAPAN), LTD. (JP) | 1997-10-09 | — | — | WO | disclosed |